'For
the quarter ending Dec 2023, consolidated Net sales (including other operating income) of Natco Pharma has increased 54.03% to Rs 758.6 crore compared to quarter ended Dec 2022. Sales of Pharmaceutical segment has gone up 54.27% to Rs 744.50 crore (accounting for 98.14% of total sales). Sales of Agro Chemical segment has gone up 42.42% to Rs 14.10 crore (accounting for 1.86% of total sales). Profit before interest, tax and other unallocable items (PBIT) has jumped 206.22% to Rs 260.90 crore. PBIT of Pharmaceutical segment rose 208.61% to Rs 275.90 crore (accounting for 105.75% of total PBIT). PBIT of Agro Chemical segment fell 257.14% to Rs -15.00 crore (accounting for -5.75% of total PBIT).
PBIT margin of Pharmaceutical segment rose from 18.52% to 37.06%. PBIT margin of Agro Chemical segment fell from negative 42.42% to negative 106.38%. Overall PBIT margin rose from 17.3...
Pleaselogin & subscribe to view the full report.
More Reports
-
-
-
Capex for the quarter was Rs 2,857 crore
-
(31-Jan-2025)
GAIL (India)
|